Independent Advisor Alliance Invests $4.40 Million in Aflac Incorporated (NYSE:AFL)

Independent Advisor Alliance bought a new position in Aflac Incorporated (NYSE:AFL) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 39,393 shares of the financial services provider’s stock, valued at approximately $4,404,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Y.D. More Investments Ltd acquired a new position in shares of Aflac in the 2nd quarter worth approximately $25,000. Darwin Wealth Management LLC acquired a new position in shares of Aflac in the 3rd quarter worth approximately $34,000. Covestor Ltd boosted its holdings in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares in the last quarter. Kennebec Savings Bank acquired a new position in Aflac during the 3rd quarter worth $45,000. Finally, Catalyst Capital Advisors LLC acquired a new position in Aflac during the 3rd quarter worth $51,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. JPMorgan Chase & Co. upped their price objective on Aflac from $85.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, October 3rd. TD Cowen assumed coverage on Aflac in a report on Wednesday, October 9th. They set a “hold” rating and a $102.00 price objective on the stock. UBS Group upped their price objective on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Barclays assumed coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price objective on the stock. Finally, Truist Financial upped their price objective on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $97.93.

Aflac Price Performance

AFL opened at $112.39 on Monday. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50. The company has a fifty day simple moving average of $110.73 and a 200 day simple moving average of $100.66. The stock has a market cap of $62.44 billion, a P/E ratio of 16.93, a P/E/G ratio of 2.17 and a beta of 0.96.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The business had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $4.30 billion. During the same quarter in the prior year, the company earned $1.84 EPS. The firm’s quarterly revenue was down 40.4% on a year-over-year basis. On average, research analysts expect that Aflac Incorporated will post 7.22 EPS for the current year.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.78%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s dividend payout ratio (DPR) is presently 30.12%.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.